PDE4A and pulmonary fibrosis: After establishing both prophylactic and therapeutic efficacy of PDE4 inhibition in mitigating type II AEC‐injury‐induced lung fibrosis, we performed studies to gain insight into the mechanisms by which this class of drugs exerts its antifibrotic effect.